pro medicus - PMCUF

PMCUF

Close Chg Chg %
155.09 -11.02 -7.11%

Closed Market

144.07

-11.02 (7.11%)

Volume: 38.00

Last Updated:

Dec 24, 2025, 10:36 AM EDT

Company Overview: pro medicus - PMCUF

PMCUF Key Data

Open

$146.79

Day Range

144.07 - 146.79

52 Week Range

100.45 - 218.25

Market Cap

$16.21B

Shares Outstanding

104.51M

Public Float

53.08M

Beta

1.50

Rev. Per Employee

N/A

P/E Ratio

197.10

EPS

N/A

Yield

25.26%

Dividend

$0.20

EX-DIVIDEND DATE

Sep 3, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

251.05

 

PMCUF Performance

1 Week
 
4.85%
 
1 Month
 
-10.17%
 
3 Months
 
-27.19%
 
1 Year
 
15.98%
 
5 Years
 
N/A
 

PMCUF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About pro medicus - PMCUF

Pro Medicus Ltd. engages in the development and supply of healthcare imaging software, Radiology Information System (RIS), and services to hospitals. It operates through the following geographical segments: Australia, Europe, and North America. The firm’s products include Visage 7 and Visage RIS. The company was founded by Sam Aaron Hupert and Anthony Barry Hall in 1983 and is headquartered in Richmond, Australia.

PMCUF At a Glance

Pro Medicus Ltd.
450 Swan Street
Richmond, Victoria (VIC) 3121
Phone 61-3-9429-8800 Revenue 137.93M
Industry Services to the Health Industry Net Income 74.62M
Sector Health Services 2025 Sales Growth 30.334%
Fiscal Year-end 06 / 2026 Employees 132
View SEC Filings

PMCUF Valuation

P/E Current 197.102
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 261.589
Price to Sales Ratio 141.762
Price to Book Ratio 115.893
Price to Cash Flow Ratio 253.99
Enterprise Value to EBITDA 181.799
Enterprise Value to Sales 140.779
Total Debt to Enterprise Value 0.00

PMCUF Efficiency

Revenue/Employee 1,044,942.789
Income Per Employee 565,288.634
Receivables Turnover 3.266
Total Asset Turnover 0.70

PMCUF Liquidity

Current Ratio 6.469
Quick Ratio 6.467
Cash Ratio 4.849

PMCUF Profitability

Gross Margin 79.424
Operating Margin 74.039
Pretax Margin 76.68
Net Margin 54.098
Return on Assets 37.888
Return on Equity 50.80
Return on Total Capital 43.924
Return on Invested Capital 50.446

PMCUF Capital Structure

Total Debt to Total Equity 0.878
Total Debt to Total Capital 0.87
Total Debt to Total Assets 0.666
Long-Term Debt to Equity 0.621
Long-Term Debt to Total Capital 0.616
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Pro Medicus - PMCUF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
67.78M 84.01M 105.83M 137.93M
Sales Growth
+33.85% +23.96% +25.97% +30.33%
Cost of Goods Sold (COGS) incl D&A
16.81M 21.88M 25.68M 28.38M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
5.31M 5.33M 5.58M 4.69M
Depreciation
589.58K 561.66K 555.03K 643.10K
Amortization of Intangibles
4.72M 4.77M 5.02M 4.04M
COGS Growth
+6.19% +30.18% +17.36% +10.51%
Gross Income
50.97M 62.13M 80.15M 109.55M
Gross Income Growth
+46.43% +21.90% +29.00% +36.69%
Gross Profit Margin
+75.20% +73.95% +75.73% +79.42%
2022 2023 2024 2025 5-year trend
SG&A Expense
5.72M 5.71M 6.59M 7.43M
Research & Development
- - - -
-
Other SG&A
5.72M 5.71M 6.59M 7.43M
SGA Growth
+79.22% -0.22% +15.36% +12.71%
Other Operating Expense
- - - -
-
Unusual Expense
1.69M 199.78K (701.81K) (63.47K)
EBIT after Unusual Expense
43.56M 56.22M 74.26M 102.19M
Non Operating Income/Expense
2.19M 1.72M 2.08M 3.58M
Non-Operating Interest Income
470.65K 1.64M 3.17M 4.90M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
45.74M 57.93M 76.34M 105.77M
Pretax Income Growth
+43.04% +26.64% +31.77% +38.55%
Pretax Margin
+67.49% +68.96% +72.13% +76.68%
Income Tax
13.52M 17.14M 22.09M 31.15M
Income Tax - Current - Domestic
13.42M 18.59M 23.23M 32.90M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
93.55K (1.45M) (1.14M) (1.75M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
32.23M 40.79M 54.25M 74.62M
Minority Interest Expense
- - - -
-
Net Income
32.23M 40.79M 54.25M 74.62M
Net Income Growth
+40.05% +26.58% +32.99% +37.53%
Net Margin Growth
+47.55% +48.56% +51.27% +54.10%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
32.23M 40.79M 54.25M 74.62M
Preferred Dividends
- - - -
-
Net Income Available to Common
32.23M 40.79M 54.25M 74.62M
EPS (Basic)
0.309 0.3907 0.5195 0.7142
EPS (Basic) Growth
+39.88% +26.44% +32.97% +37.48%
Basic Shares Outstanding
104.31M 104.41M 104.44M 104.48M
EPS (Diluted)
0.3082 0.3901 0.5184 0.7129
EPS (Diluted) Growth
+40.09% +26.57% +32.89% +37.52%
Diluted Shares Outstanding
104.58M 104.59M 104.65M 104.66M
EBITDA
50.55M 61.75M 79.13M 106.81M
EBITDA Growth
+36.68% +22.16% +28.16% +34.97%
EBITDA Margin
+74.58% +73.50% +74.77% +77.44%

Pro Medicus in the News